The fact
The French biotech is upgraded by Jefferies and Barclays ahead of a financial operation.
Investors await details on the subscription price and long-term scenarios.
Click the link to read an article on the topic:
The French biotech is upgraded by Jefferies and Barclays ahead of a financial operation.
Investors await details on the subscription price and long-term scenarios.